Pavel Jansa

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

Tomás Pulido, Igor Adzerikho, Richard N. Channick et al. · New England Journal of Medicine · 2013 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

Andrea Maria D’Armini, Friedrich Grimminger, Marius M. Hoeper et al. · New England Journal of Medicine · 2013 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Joanna Pepke‐Żaba, Marion Delcroix, Iréne Lang et al. · Circulation · 2011 · 1K citations · Full text

Medicine, Cardiology, Surgery +16

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

Nazzareno Galiè, LJ Rubin, Pavel Jansa et al. · The Lancet · 2008 · 917 citations

Medicine, Internal Medicine, Pharmacotherapy +6

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension

Marion Delcroix, Iréne Lang, Joanna Pepke‐Żaba et al. · Circulation · 2016 · 666 citations

Medicine, Surgery, Cardiothoracic Surgery +11